J Korean Pain Soc.
2000 Jun;13(1):49-54.
Intra-pelvic Morphine, Morphine-Bupivacaine Instillation for Pain Relief
after Endoscopic Pelvic Surgery
- Affiliations
-
- 1Department of Anesthesiology, Gachon Medical College, Inchon, Korea.
- 2Department of Obstetrics & Gynecology, Gachon Medical College, Inchon, Korea.
Abstract
-
BACKGROUND: Evidence has accumulated that opioids can produce potent antinociceptive
effects by interacting with opioid receptors in peripheral tissues. Bupivacaine has a
potent analgesic effect with early peak onset in the postoperative period. The combination
of intrapelvic bupivacaine and morphine has been suggested as an ideal analgesic after
endoscopic pelvic surgery.
METHODS
Sixty patients scheduled for endoscopic pelvic surgery under general anesthesia
were allocated randomly to three groups. Group 1 received normal saline 20 ml, group 2
received morphine 5 mg in normal saline 20 ml, and group 3 received morphine 5 mg in 0.25%
bupivacaine 20 ml into the pelvic cavity. Postoperative pain was assessed using the visual
analogue scale at I, 2, 4, 8, and 24 hours after the intrapelvic instillation. Supplemental
analgesic requirements, vital signs, and side effects were recorded for 24 hours.
RESULTS
Intrapelvic morphine and bupivacaine produced significant analgesia after
endoscopic pelvic surgery. The patients in group 3 had lower pain scores than those
in the group 1 and 2 at 1, 2 and 4th hours. There were no significant differences
in the pain scores at 8 hours and 24 hours postoperatively between group 2 and 3.
Supplemental analgesic requirements were significantly greater in the groups 1 and 2 than
the group 3 for 24 hours. No significant side effects occurred.
CONCLUSION
The intrapelvic instillation of morphine and bupivacaine is effective for
the postoperative pain control in patients undergoing endoscopic pelvic surgery.